Skip to content

Clinical trials

Terminated Observational Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Observational Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20061
20082
20112
20161
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag, S.A.2
National Institute of Mental Health (NIMH)2
AstraZeneca1
Hôpital NOVO1
National Alliance on Mental Illness New Hampshire1
Northwestern University1
Nova Scotia Health Authority1
TheraGenetics Limited1
University Hospital, Akershus1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders13
Schizophrenia10
Bipolar Disorder2
Mental Disorders2
Hypersensitivity1
Schizophrenia, Childhood1
Schizophrenia, Paranoid1
Weight Gain1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.